Business Segments · Total segment depreciation and amortization
Prescription Technology Solutions — Total segment depreciation and amortization
McKesson Prescription Technology Solutions — Total segment depreciation and amortization decreased by 4.8% to $20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.8%, from $21M to $20M. Over 4 years (FY 2022 to FY 2026), Prescription Technology Solutions — Total segment depreciation and amortization shows relatively stable performance with a 0.0% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2026May 8, 2026
Rolls up toD&A
How to read this metric
An increase often reflects high levels of capital investment or recent acquisitions of technology assets.
Detailed definition
This metric represents the total non-cash charges for the depreciation of tangible assets and the amortization of intang...
Peer comparison
Standard depreciation and amortization metric reported for all business segments in financial statements.
Metric ID:
mck_segment_prescription_technology_solutions_total_segment_depreciation_and_amortizationHistorical Data
20 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.5M | $20.5M | $20.5M | $20.5M | $19.25M | $19.25M | $19.25M | $19.25M | $21M | $21M | $21M | $21M | $21M | $22M | $22M | $21M | $21M | $20M | $21M | $20M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -6.1% | +0.0% | +0.0% | +0.0% | +9.1% | +0.0% | +0.0% | +0.0% | +0.0% | +4.8% | +0.0% | -4.5% | +0.0% | -4.8% | +5.0% | -4.8% |
| YoY Change | — | — | — | — | -6.1% | -6.1% | -6.1% | -6.1% | +9.1% | +9.1% | +9.1% | +9.1% | +0.0% | +4.8% | +4.8% | +0.0% | +0.0% | -9.1% | -4.5% | -4.8% |
Range$19.25M – $22M
CAGR-0.5%
Avg YoY Growth+0.2%
Median YoY Growth+0.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — total segment depreciation and amortization?
- McKesson (MCK) reported prescription technology solutions — total segment depreciation and amortization of $20M in Q1 2026.
- How has McKesson's prescription technology solutions — total segment depreciation and amortization changed year-over-year?
- McKesson's prescription technology solutions — total segment depreciation and amortization decreased by 4.8% year-over-year, from $21M to $20M.
- What is the long-term trend for McKesson's prescription technology solutions — total segment depreciation and amortization?
- Over 4 years (2022 to 2026), McKesson's prescription technology solutions — total segment depreciation and amortization has grown at a 0.0% compound annual growth rate (CAGR), from $82M to $82M.
- What does prescription technology solutions — total segment depreciation and amortization mean?
- The total non-cash expense for the wear and tear of assets and the write-off of intangible assets in this segment.